by Holly Roenicke | May 28, 2025 | Home Page Featured Story, May 2025, News
Overview Phase 2 of Axia’s End-to-End Pilot was built on the success of Phase 1, which demonstrated the technical feasibility of applying RFID to various drug formulations and pharmaceutical packaging types in a laboratory setting. Phase 2 significantly expanded...
by Holly Roenicke | May 8, 2025 | Home Page Featured Story, May 2025
PRESENTING From Pilot to Practice: RFID’s Role in Pharma Supply Chains Wednesday, May 7 On Wednesday, May 7, Axia’s Dr. Bahar Aliakbarian, Senior R&D Director, and John Hatfield, Executive Director, presented at RFID Journal Live 2025. They presented...
by Holly Roenicke | May 7, 2025 | Home Page Featured Story, May 2025, News
Healthcare Consortium Meets in Detroit May 7, 2025 On April 30th, Axia brought together more than 20 member companies from the Healthcare Consortium at the MSU Detroit Center to review recent research and project accomplishments, and to brainstorm future research that...
by Holly Roenicke | Mar 27, 2025 | Home Page Featured Story, March 2025, News
Your Chance to Develop New Solutions to Circularity Challenges High School and College Teams Compete for Cash Prizes The Go Green!! Hackathon brings together secondary (high school) and collegiate interdisciplinary teams for a collaborative learning experience in...
by Holly Roenicke | Feb 6, 2025 | February 2025, Home Page Featured Story, News
Axia Designs New Test Protocols for Pharmaceutical RFID Tags February 2025 Adopted as global standard by GS1 The Axia Lab™ of Michigan State University recently concluded leading an initiative to create a new test protocol for grading the performance of radio...
by Holly Roenicke | Feb 4, 2025 | February 2025, Home Page Featured Story, News
Axia Selected as NextCyle Michigan Team for 2025 Recycling Project Accelerator (Supply Chain Track) February 4, 2025 MIDLAND, MI – The Axia Institute has been selected to participate in the NextCycle Michigan project accelerator program designed to help improve...
Recent Comments